Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Management and treatment of children with medulloblastoma in Serbia, a middle-income country.

Bokun J, Grujicic D, Skender-Gazibara M, Paripovic L, Pekmezovic T, Kisic-Tepavcevic D, Ilic V, Raicevic S, Stanic D, Miskovic I, Saric M, Nikitovic M.

J BUON. 2018 Jul-Aug;23(4):1156-1162.

PMID:
30358225
2.
3.
4.

Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.

Wang C, Yuan XJ, Jiang MW, Wang LF.

J Neurosurg Pediatr. 2016 Jan;17(1):49-56. doi: 10.3171/2015.5.PEDS1573. Epub 2015 Oct 9.

PMID:
26451721
5.

Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss Pediatric Oncology Group.

Miralbell R, Bieri S, Huguenin P, Feldges A, Morin AM, Garcia E, Wagner HP, Wacker P, von der Weid N.

Ann Oncol. 1999 Feb;10(2):239-41.

PMID:
10093696
6.

Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.

Mehrvar A, Tashvighi M, Hedayati Asl AA, Niktoreh-Mofrad N, Mehrvar N, Afsar N, Naderi A, Allebouyeh M, Qaddoumi I, Faranoush M.

Childs Nerv Syst. 2018 Apr;34(4):639-647. doi: 10.1007/s00381-017-3672-y. Epub 2017 Dec 6.

PMID:
29214340
7.

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79.

PMID:
10661332
8.

A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.

Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Deinlein F, Benesch M, Zwiener I, Soerensen N, Warmuth-Metz M, Pietsch T, Mittler U, Kuehl J, Kortmann RD, Grotzer MA, Rutkowski S.

Eur J Cancer. 2012 Sep;48(13):2028-36. doi: 10.1016/j.ejca.2011.11.012. Epub 2011 Dec 6.

9.

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ.

J Clin Oncol. 1999 Mar;17(3):832-45.

PMID:
10071274
10.

Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.

Hartsell WF, Gajjar A, Heideman RL, Langston JA, Sanford RA, Walter A, Jones D, Chen G, Kun LE.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):15-24.

PMID:
9300735
11.

Survival and prognostic factors in a series of adults with medulloblastomas.

Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.

J Neurosurg. 2009 Sep;111(3):478-87. doi: 10.3171/2009.1.JNS081004.

PMID:
19231932
12.

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children's Cancer Study Group.

J Clin Oncol. 2003 Apr 15;21(8):1581-91.

PMID:
12697884
13.

M1 Medulloblastoma: high risk at any age.

Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant TE, Gajjar A.

J Neurooncol. 2008 Dec;90(3):351-5. doi: 10.1007/s11060-008-9671-9. Epub 2008 Aug 15.

14.

Late toxicity following craniospinal radiation for early-stage medulloblastoma.

Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ.

Acta Oncol. 2014 Apr;53(4):471-80. doi: 10.3109/0284186X.2013.862596. Epub 2014 Feb 24.

PMID:
24564687
15.

Adult medulloblastoma: a single institution experience.

Nazmy M, Khafaga Y, Al Hebshi A, Hassounah M, Albadawy S.

Gulf J Oncolog. 2014 Jul;1(16):27-31.

PMID:
25316389
16.

[Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].

Golubicić I, Bokun J, Nikitović M, Mladenović J, Sarić M, Bekić Z.

Srp Arh Celok Lek. 2003 May-Jun;131(5-6):226-31. Serbian.

17.

Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single Institution.

Lee DS, Cho J, Kim SH, Kim DS, Shim KW, Lyu CJ, Han JW, Suh CO.

Cancer Res Treat. 2015 Oct;47(4):879-88. doi: 10.4143/crt.2014.067. Epub 2014 Dec 8.

18.

Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.

Walter AW, Mulhern RK, Gajjar A, Heideman RL, Reardon D, Sanford RA, Xiong X, Kun LE.

J Clin Oncol. 1999 Dec;17(12):3720-8.

PMID:
10577843
19.

Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children.

Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB.

JAMA Oncol. 2016 Dec 1;2(12):1574-1581. doi: 10.1001/jamaoncol.2016.2547. Erratum in: JAMA Oncol. 2016 Dec 1;2(12 ):1661.

PMID:
27491009
20.

Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.

Yoon JH, Park KD, Kang HJ, Kim H, Lee JW, Kim SK, Wang KC, Park SH, Kim IH, Shin HY.

World J Pediatr. 2017 Aug;13(4):367-373. doi: 10.1007/s12519-017-0044-3. Epub 2017 May 27.

PMID:
28550392

Supplemental Content

Support Center